Alvotech Achieves Japan Milestone, Expands In Canada

Icelandic Firm Files Undisclosed First Biosimilar Via Partner Fuji Pharma

Alvotech has swiftly advanced in Japan and Canada, as part of its mission to introduce its pipeline of biosimilars across the globe.

Japan
Fuji had invested in Alvotech before it went public • Source: Shutterstock

More from Biosimilars

More from Products